blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3613742

EP3613742 - INDOLIZINE DERIVATIVES AND APPLICATION THEREOF IN MEDICINE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.10.2023
Database last updated on 13.11.2024
FormerThe patent has been granted
Status updated on  04.11.2022
FormerGrant of patent is intended
Status updated on  21.08.2022
FormerRequest for examination was made
Status updated on  24.01.2020
FormerThe international publication has been made
Status updated on  17.11.2018
Most recent event   Tooltip19.04.2024Lapse of the patent in a contracting state
New state(s): IE		published on 22.05.2024  [2024/21]
Applicant(s)For all designated states
Kind Pharmaceutical
Floor 17 Building 4
Health Valley
1500 West Wenyi Road
Hangzhou, Zhejiang 311122 / CN
[2020/09]
Inventor(s)01 / LIU, Dong
Floor 17 Building 4
Health Valley
1500 West Wenyi Road
Hangzhou Zhejiang 311122 / CN
02 / CHEN, Dongdong
Floor 17 Building 4
Health Valley
1500 West Wenyi Road
Hangzhou Zhejiang 311122 / CN
03 / DENG, Biao
Floor 17 Building 4
Health Valley
1500 West Wenyi Road
Hangzhou Zhejiang 311122 / CN
04 / TU, Xiangyun
Floor 17 Building 4
Health Valley
1500 West Wenyi Road
Hangzhou Zhejiang 311122 / CN
05 / FANG, Zinan
Floor 17 Building 4
Health Valley
1500 West Wenyi Road
Hangzhou Zhejiang 311122 / CN
06 / WU, Haohao
Floor 17 Building 4
Health Valley
1500 West Wenyi Road
Hangzhou Zhejiang 311122 / CN
07 / GU, Danyan
Floor 17 Building 4
Health Valley
1500 West Wenyi Road
Hangzhou Zhejiang 311122 / CN
 [2020/09]
Representative(s)Prüfer & Partner mbB Patentanwälte · Rechtsanwälte
Sohnckestraße 12
81479 München / DE
[2020/09]
Application number, filing date18798694.808.05.2018
[2020/09]
WO2018CN86025
Priority number, dateCN20171032237709.05.2017         Original published format: CN201710322377
[2020/09]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018205928
Date:15.11.2018
Language:ZH
[2018/46]
Type: A1 Application with search report 
No.:EP3613742
Date:26.02.2020
Language:EN
[2020/09]
Type: B1 Patent specification 
No.:EP3613742
Date:07.12.2022
Language:EN
[2022/49]
Search report(s)International search report - published on:CN15.11.2018
(Supplementary) European search report - dispatched on:EP04.12.2020
ClassificationIPC:C07D471/10, A61K31/438, A61P7/06, C07D471/04, C07D491/20, A61K31/437
[2021/01]
CPC:
A61P7/06 (EP,CN); C07D471/04 (EP,CN,US); A61K31/437 (EP);
A61K31/438 (EP); A61K31/444 (EP); A61P1/16 (EP,CN);
A61P11/00 (EP,CN); A61P13/12 (EP,CN); A61P15/10 (EP,CN);
A61P19/02 (EP,CN); A61P25/00 (EP,CN); A61P25/16 (EP,CN);
A61P25/28 (EP,CN); A61P27/02 (EP,CN); A61P27/06 (EP,CN);
A61P29/00 (EP,CN); A61P3/10 (EP,CN); A61P31/18 (EP,CN);
A61P35/00 (EP,CN); A61P7/00 (US); A61P9/00 (EP,CN);
A61P9/10 (EP,CN); A61P9/12 (EP,CN); C07D471/10 (EP);
C07D491/20 (EP,CN,US) (-)
Former IPC [2020/09]C07D471/10, A61K31/438, A61P35/00, A61P7/06, A61P9/00, A61P9/10
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/09]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:INDOLIZINDERIVATE UND DEREN ANWENDUNG IN DER MEDIZIN[2020/09]
English:INDOLIZINE DERIVATIVES AND APPLICATION THEREOF IN MEDICINE[2020/09]
French:DÉRIVÉS D'INDOLIZINE ET LEUR APPLICATION EN MÉDECINE[2020/09]
Entry into regional phase19.11.2019Translation filed 
19.11.2019National basic fee paid 
19.11.2019Search fee paid 
19.11.2019Designation fee(s) paid 
19.11.2019Examination fee paid 
Examination procedure19.11.2019Examination requested  [2020/09]
12.03.2021Amendment by applicant (claims and/or description)
22.08.2022Communication of intention to grant the patent
28.10.2022Fee for grant paid
28.10.2022Fee for publishing/printing paid
28.10.2022Receipt of the translation of the claim(s)
Opposition(s)08.09.2023No opposition filed within time limit [2023/46]
Fees paidRenewal fee
29.04.2020Renewal fee patent year 03
28.04.2021Renewal fee patent year 04
27.04.2022Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL07.12.2022
AT07.12.2022
CZ07.12.2022
DK07.12.2022
EE07.12.2022
HR07.12.2022
LT07.12.2022
LV07.12.2022
MC07.12.2022
PL07.12.2022
RO07.12.2022
RS07.12.2022
SI07.12.2022
SK07.12.2022
SM07.12.2022
NO07.03.2023
GR08.03.2023
IS07.04.2023
PT10.04.2023
IE08.05.2023
LU08.05.2023
[2024/21]
Former [2024/08]AL07.12.2022
AT07.12.2022
CZ07.12.2022
DK07.12.2022
EE07.12.2022
HR07.12.2022
LT07.12.2022
LV07.12.2022
MC07.12.2022
PL07.12.2022
RO07.12.2022
RS07.12.2022
SI07.12.2022
SK07.12.2022
SM07.12.2022
NO07.03.2023
GR08.03.2023
IS07.04.2023
PT10.04.2023
LU08.05.2023
Former [2023/51]AL07.12.2022
AT07.12.2022
CZ07.12.2022
DK07.12.2022
EE07.12.2022
HR07.12.2022
LT07.12.2022
LV07.12.2022
PL07.12.2022
RO07.12.2022
RS07.12.2022
SI07.12.2022
SK07.12.2022
SM07.12.2022
NO07.03.2023
GR08.03.2023
IS07.04.2023
PT10.04.2023
Former [2023/46]AL07.12.2022
AT07.12.2022
CZ07.12.2022
DK07.12.2022
EE07.12.2022
HR07.12.2022
LT07.12.2022
LV07.12.2022
PL07.12.2022
RO07.12.2022
RS07.12.2022
SK07.12.2022
SM07.12.2022
NO07.03.2023
GR08.03.2023
IS07.04.2023
PT10.04.2023
Former [2023/39]AL07.12.2022
AT07.12.2022
CZ07.12.2022
EE07.12.2022
HR07.12.2022
LT07.12.2022
LV07.12.2022
PL07.12.2022
RO07.12.2022
RS07.12.2022
SK07.12.2022
SM07.12.2022
NO07.03.2023
GR08.03.2023
IS07.04.2023
PT10.04.2023
Former [2023/38]AL07.12.2022
AT07.12.2022
CZ07.12.2022
EE07.12.2022
HR07.12.2022
LT07.12.2022
LV07.12.2022
PL07.12.2022
RO07.12.2022
RS07.12.2022
SK07.12.2022
SM07.12.2022
NO07.03.2023
GR08.03.2023
PT10.04.2023
Former [2023/37]AL07.12.2022
AT07.12.2022
CZ07.12.2022
EE07.12.2022
HR07.12.2022
LT07.12.2022
LV07.12.2022
PL07.12.2022
RO07.12.2022
RS07.12.2022
SM07.12.2022
NO07.03.2023
GR08.03.2023
PT10.04.2023
Former [2023/35]AT07.12.2022
CZ07.12.2022
EE07.12.2022
HR07.12.2022
LT07.12.2022
LV07.12.2022
PL07.12.2022
RO07.12.2022
RS07.12.2022
SM07.12.2022
NO07.03.2023
GR08.03.2023
PT10.04.2023
Former [2023/34]EE07.12.2022
HR07.12.2022
LT07.12.2022
LV07.12.2022
PL07.12.2022
RS07.12.2022
SM07.12.2022
NO07.03.2023
GR08.03.2023
PT10.04.2023
Former [2023/33]HR07.12.2022
LT07.12.2022
LV07.12.2022
PL07.12.2022
RS07.12.2022
SM07.12.2022
NO07.03.2023
GR08.03.2023
Former [2023/25]HR07.12.2022
LT07.12.2022
LV07.12.2022
PL07.12.2022
RS07.12.2022
NO07.03.2023
GR08.03.2023
Former [2023/23]LT07.12.2022
LV07.12.2022
NO07.03.2023
GR08.03.2023
Former [2023/20]LT07.12.2022
NO07.03.2023
Documents cited:Search[A]US2010047367  (DENG SHAOJIANG [US], et al) [A] 1-15* claims 1-32 *
International search[A]WO2004108681  (FIBROGEN INC [US], et al) [A] 1-20;
 [A]WO2008134553  (XENON PHARMACEUTICALS INC [CA], et al) [A] 1-20;
 [A]CN101460223  (KALYPSYS INC [US])[A] 1-20;
 [A]WO2014102818  (CADILA HEALTHCARE LTD [IN]) [A] 1-20;
 [PX]CN107739378  (HANGZHOU ANDAO PHARMACEUTICAL CO LTD) [PX] 1-20
by applicantEP0661269
 WO2004108681
 WO2007070359
 WO2007150011
 WO2008076425
 WO2011007856
 WO2011042477
 WO2012006472
 WO2013043621
 WO2014102818
    - Cell, (20010000), vol. 107, pages 43 - 54
    - Molecular Cellular Biology, (19920000), vol. 12, pages 5447 - 5454
    - Nature Reviews Cancer, (20030000), vol. 3, pages 721 - 732
    - Science, (20010000), vol. 292, pages 464 - 468
    - J. Med. Chem., (19920000), vol. 35, pages 2652 - 2658
    - J. Med. Chem, (19930000), vol. 36, pages 3853 - 3858
    - Synlett, (20020000), vol. 7, pages 1152 - 1154
    - CHEMICAL ABSTRACTS, Database accession no. 808118-40-3
    - ACS Combinatorial Sciences, (20160000), vol. 18, no. 6, pages 330 - 336
    - J. Chem . Soc., (19610000), pages 4372 - 9
    - Liebis Annalen der Chemie, (19890000), vol. 9, pages 863 - 881
    - Anal Biochem, (20040000), vol. 330, pages 74 - 80
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.